A Multinational Investigation of Time and Traveling Costs in Attending Anticoagulation Clinics
- 1 March 2008
- journal article
- research article
- Published by Elsevier in Value in Health
- Vol. 11 (2) , 207-212
- https://doi.org/10.1111/j.1524-4733.2007.00253.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trialThe Lancet, 2003
- ABC of antithrombotic therapy: Anticoagulation in hospitals and general practiceBMJ, 2003
- Analysis of cost data in randomized trials: an application of the non-parametric bootstrapStatistics in Medicine, 2000
- Costs Incurred by Patients Undergoing Advanced Colorectal Cancer TherapyPharmacoEconomics, 2000
- Estimating time and travel costs incurred in clinic based screening: flexible sigmoidoscopy screening for colorectal cancerJournal of Medical Screening, 1999
- Private Costs Associated with Abdominal Aortic Aneurysm Screening: The Importance of Private Travel and Time CostsJournal of Medical Screening, 1995
- Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective.BMJ, 1992
- Antithrombotic treatment and atrial fibrillation.BMJ, 1992
- The Costs of Treating Hypertension in SwedenScandinavian Journal of Primary Health Care, 1991